RecruitingPhase 2NCT05758389

Tislelizumab Combined APF Chemotherapy in the Treatment of Locally Advanced Head and Neck Tumors

Studying Anorectal malformation

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Intervention
Tislelizumab, Paclitaxel (albumin-bound type), Cisplatin, 5-FU(drug)
Enrollment
29 target
Eligibility
18-75 years · All sexes
Timeline
20222025

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05758389 on ClinicalTrials.gov

Other trials for Anorectal malformation

Additional recruiting or active studies for the same condition.

See all trials for Anorectal malformation

← Back to all trials